Burning Rock Biotech Limited provides revenue guidance for the year 2023. for the year, the company expects revenues to grow approximately 20% over 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.3 USD | +3.36% | +6.48% | -10.75% |
04-02 | Earnings Flash (BNR.L) BURNING ROCK BIOTECH Posts FY23 Revenue $75.7M | MT |
04-02 | Earnings Flash (BNR.L) BURNING ROCK BIOTECH Posts FY23 Loss $-0.90 | MT |
1st Jan change | Capi. | |
---|---|---|
-10.75% | 82.38M | |
-16.99% | 8.67B | |
+65.23% | 4.25B | |
-1.10% | 2.51B | |
-10.68% | 2.47B | |
-41.76% | 2.25B | |
-8.53% | 1.91B | |
-19.29% | 1.56B | |
-39.61% | 1.19B | |
+9.54% | 1.15B |
- Stock Market
- Equities
- BNR Stock
- News Burning Rock Biotech Limited
- Burning Rock Biotech Limited Provides Revenue Guidance for the Year 2023